Clinical trial
Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer
NCT01803269
Study timeline
Study start (actual)2013-01-16Date precision: day
Registry last updated2020-06-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Extensive Stage Small Cell Lung Cancerunresolved
Recurrent Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
University of Chicagolead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01803269 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.